For research use only. Not for therapeutic Use.
Teduglutide-d8 (Leu-d3+Phe-d5)（Cat No.:R035916） is a deuterated form of teduglutide, enhanced with three deuterium atoms in the leucine residues and five in the phenylalanine residues. This isotopic enrichment allows for precise pharmacokinetic and pharmacodynamic studies, especially in gastrointestinal research where teduglutide is used to treat short bowel syndrome. By stabilizing the peptide against enzymatic degradation, Teduglutide-d8 provides more reliable data in clinical trials and biological studies. It is an essential tool for researchers aiming to understand and improve peptide-based therapies.
| Catalog Number | R035916 |
| CAS Number | NA |
| Synonyms | 1: PN: US20130072430 SEQID: 4 Claimed Protein-d8; ALX 0600-d8; Gattex-d8; Glucagon-like Peptide II [2-Glycine] (Human)-d8; Revestive-d8; |
| Molecular Formula | C₁₆₄H₂₄₄D₈N₄₄O₅₅S |
| Purity | ≥95% |
| Storage | Store at +4C |
